Mechanisms of target organ damage caused by hypertension: Therapeutic potential

被引:122
作者
Cohuet, G. [1 ]
Struijker-Boudier, H. [1 ]
机构
[1] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
关键词
hypertension; target organ damage; microcirculation; therapy ronasdsd;
D O I
10.1016/j.pharmthera.2005.09.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension is a major risk factor for cardiovascular mortality and morbidity through its effects on target organs like the brain, heart, and kidney. Structural alterations in the microcirculation form a major link between hypertension and target organ damage. In this review, we describe damages related to hypertension in these target organs and the mechanisms involved in the pathogenesis of hypertension-induced cardiovascular diseases such as dementia, cardiac ischemia and remodeling, or nephropathy. We also focus on the therapeutical potential on the basis of such mechanisms. Several antihypertensive agents like diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin II (Ang II) receptor antagonists, beta-blockers, or calcium channel blockers (CCBs) have been shown to reduce effectively hypertension associated cardiovascular events and to improve end organ damage. More recently, aldosterone antagonism has also shown beneficial effects. Part of the favorable effects of these agents is due to blood pressure lowering as such. Other mechanisms such as oxidative stress, inflammation, or endothelial dysfunction have appeared to play a key role in the pathogenesis of target organ damage and therefore represent another important pathway for therapy. In this review, we discuss the different therapeutic approaches aiming at reducing cardiovascular events and damages induced by hypertension. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 98
页数:18
相关论文
共 240 条
[51]   Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) [J].
Davis, BR ;
Cutler, JA ;
Gordon, DJ ;
Furberg, CD ;
Wright, JT ;
Cushman, WC ;
Grimm, RH ;
LaRosa, J ;
Whelton, PK ;
Perry, HM ;
Alderman, MH ;
Ford, CE ;
Oparil, S ;
Francis, C ;
Proschan, M ;
Pressel, S ;
Black, HR ;
Hawkins, CM .
AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (04) :342-360
[52]   Clinical significance of renal function in hypertensive patients at high risk - Results from the INSIGHT trial [J].
de Leeuw, PW ;
Ruilope, LM ;
Palmer, CR ;
Brown, MJ ;
Castaigne, A ;
Mancia, G ;
Rosenthal, T ;
Wagener, G .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (22) :2459-2464
[53]   Molecular mechanisms of myocardial remodeling. The role of aldosterone [J].
Delcayre, C ;
Swynghedauw, B .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (12) :1577-1584
[54]   The heat shock paradox:: does NF-κB determine cell fate? [J].
DeMeester, SL ;
Buchman, TG ;
Cobb, JP .
FASEB JOURNAL, 2001, 15 (01) :270-274
[55]   POSSIBLE IMPORTANCE OF ALDOSTERONE AS WELL AS RENIN IN LONG-TERM ANTIHYPERTENSIVE ACTION OF PROPRANOLOL [J].
DRAYER, JIM ;
WEBER, MA ;
LONGWORTH, DL ;
LARAGH, JH .
AMERICAN JOURNAL OF MEDICINE, 1978, 64 (02) :187-192
[56]   Hypertensive retinopathy and incident coronary heart disease in high risk men [J].
Duncan, BB ;
Wong, TY ;
Tyroler, HA ;
Davis, CE ;
Fuchs, FD .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (09) :1002-1006
[57]   Aldosterone and vascular damage [J].
Duprez D. ;
De Buyzere M. ;
Rietzschel E.R. ;
Clement D.L. .
Current Hypertension Reports, 2000, 2 (3) :327-334
[58]   Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients [J].
Duprez, DA ;
De Buyzere, NL ;
Rietzschel, ER ;
Taes, Y ;
Clement, DL ;
Morgan, D ;
Cohn, JN .
EUROPEAN HEART JOURNAL, 1998, 19 (09) :1371-1376
[59]   Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive Ren-2 transgenic rats [J].
Dvorák, P ;
Kramer, HJ ;
Bäcker, A ;
Maly, J ;
Kopkan, L ;
Vanecková, I ;
Vernerová, Z ;
Opocensky, M ;
Tesar, V ;
Bader, M ;
Ganten, D ;
Janda, J ;
Cervenka, L .
KIDNEY & BLOOD PRESSURE RESEARCH, 2004, 27 (04) :248-258
[60]   Cardiovascular events in elderly patients with isolated systolic hypertension.: A subgroup analysis of treatment strategies in STOP-Hypertension-2 [J].
Ekbom, T ;
Linjer, E ;
Hedner, T ;
Lanke, J ;
De Faire, U ;
Wester, PO ;
Dahlöf, B ;
Scherstén, B .
BLOOD PRESSURE, 2004, 13 (03) :137-143